These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 7936006

  • 21. General principles of medical therapy of inflammatory bowel disease.
    Friedman S.
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [Abstract] [Full Text] [Related]

  • 22. Conventional medical management of inflammatory bowel disease.
    Burger D, Travis S.
    Gastroenterology; 2011 May; 140(6):1827-1837.e2. PubMed ID: 21530749
    [Abstract] [Full Text] [Related]

  • 23. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS, Rubin A, Das K.
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [Abstract] [Full Text] [Related]

  • 24. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E, Bock H.
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [Abstract] [Full Text] [Related]

  • 25. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 26. The state of the art in the management of inflammatory bowel disease.
    Hanauer SB, Present DH.
    Rev Gastroenterol Disord; 2003 Jun; 3(2):81-92. PubMed ID: 12776005
    [Abstract] [Full Text] [Related]

  • 27. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 28. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V, Munkholm P.
    Ugeskr Laeger; 2001 Jan 01; 163(1):16-21. PubMed ID: 11586666
    [Abstract] [Full Text] [Related]

  • 29. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun 10; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 34. [Treatment strategies for inflammatory bowel disease].
    Lémann M, Allez M.
    Rev Prat; 2005 May 15; 55(9):984-92. PubMed ID: 16052969
    [Abstract] [Full Text] [Related]

  • 35. Current medical therapy for inflammatory bowel disease.
    Bonner GF.
    South Med J; 1996 Jun 15; 89(6):556-66. PubMed ID: 8638193
    [Abstract] [Full Text] [Related]

  • 36. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
    Hermida-Rodriguez C, Cantero Perona J, Garcia-Valriberas R, Pajares Garcia JM, Mate-Jimenez J.
    Hepatogastroenterology; 1999 Jun 15; 46(28):2265-8. PubMed ID: 10521978
    [Abstract] [Full Text] [Related]

  • 37. Management of inflammatory bowel disease in adults.
    Katz JA.
    J Dig Dis; 2007 May 15; 8(2):65-71. PubMed ID: 17532817
    [Abstract] [Full Text] [Related]

  • 38. Management of inflammatory bowel disease.
    Botoman VA, Bonner GF, Botoman DA.
    Am Fam Physician; 1998 Jan 01; 57(1):57-68, 71-2. PubMed ID: 9447214
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.